BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 7513313)

  • 1. Penner's serotype 4 of Campylobacter jejuni has a lipopolysaccharide that bears a GM1 ganglioside epitope as well as one that bears a GD1 a epitope.
    Yuki N; Taki T; Takahashi M; Saito K; Tai T; Miyatake T; Handa S
    Infect Immun; 1994 May; 62(5):2101-3. PubMed ID: 7513313
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ganglioside-like epitopes of lipopolysaccharides from Campylobacter jejuni (PEN 19) in three isolates from patients with Guillain-Barré syndrome.
    Yuki N; Handa S; Tai T; Takahashi M; Saito K; Tsujino Y; Taki T
    J Neurol Sci; 1995 May; 130(1):112-6. PubMed ID: 7544402
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lipopolysaccharides from Campylobacter jejuni O:41 strains associated with Guillain-Barré syndrome exhibit mimicry of GM1 ganglioside.
    Prendergast MM; Lastovica AJ; Moran AP
    Infect Immun; 1998 Aug; 66(8):3649-55. PubMed ID: 9673245
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human monoclonal immunoglobulin M antibodies to ganglioside GM1 show diverse cross-reactivities with lipopolysaccharides of Campylobacter jejuni strains associated with Guillain-Barré syndrome.
    Prendergast MM; Willison HJ; Moran AP
    Infect Immun; 1999 Jul; 67(7):3698-701. PubMed ID: 10377164
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Guillain-Barré syndrome- and Miller Fisher syndrome-associated Campylobacter jejuni lipopolysaccharides induce anti-GM1 and anti-GQ1b Antibodies in rabbits.
    Ang CW; De Klerk MA; Endtz HP; Jacobs BC; Laman JD; van der Meché FG; van Doorn PA
    Infect Immun; 2001 Apr; 69(4):2462-9. PubMed ID: 11254608
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ganglioside-induced antiganglioside antibodies from a neuropathy patient cross-react with lipopolysaccharides of Campylobacter jejuni associated with Guillain-Barré syndrome.
    Neisser A; Schwerer B; Bernheimer H; Moran AP
    J Neuroimmunol; 2000 Jan; 102(1):85-8. PubMed ID: 10626671
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Guillain-Barré syndrome and Fisher's syndrome following Campylobacter jejuni infection.
    Yuki N; Miyatake T
    Ann N Y Acad Sci; 1998 Jun; 845():330-40. PubMed ID: 9668366
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ganglioside GM1 mimicry in Campylobacter strains from sporadic infections in the United States.
    Nachamkin I; Ung H; Moran AP; Yoo D; Prendergast MM; Nicholson MA; Sheikh K; Ho T; Asbury AK; McKhann GM; Griffin JW
    J Infect Dis; 1999 May; 179(5):1183-9. PubMed ID: 10191221
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A bacterium lipopolysaccharide that elicits Guillain-Barré syndrome has a GM1 ganglioside-like structure.
    Yuki N; Taki T; Inagaki F; Kasama T; Takahashi M; Saito K; Handa S; Miyatake T
    J Exp Med; 1993 Nov; 178(5):1771-5. PubMed ID: 8228822
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Subclass of IgG antibody to GM1 epitope-bearing lipopolysaccharide of Campylobacter jejuni in patients with Guillain-Barré syndrome.
    Yuki N; Ichihashi Y; Taki T
    J Neuroimmunol; 1995 Jul; 60(1-2):161-4. PubMed ID: 7543907
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reactivity of serum IgG anti-GM1 ganglioside antibodies with the lipopolysaccharide fractions of Campylobacter jejuni isolates from patients with Guillain-Barre syndrome (GBS).
    Gregson NA; Rees JH; Hughes RA
    J Neuroimmunol; 1997 Mar; 73(1-2):28-36. PubMed ID: 9058756
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Guillain-Barré syndrome].
    Yuki N
    Nihon Rinsho; 1994 Nov; 52(11):2952-8. PubMed ID: 7996693
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of an immunoassay for rapid detection of ganglioside GM(1) mimicry in Campylobacter jejuni strains.
    Prendergast MM; Kosunen TU; Moran AP
    J Clin Microbiol; 2001 Apr; 39(4):1494-500. PubMed ID: 11283076
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular mimicry between gangliosides and lipopolysaccharides of Campylobacter jejuni isolated from patients with Guillain-Barré syndrome and Miller Fisher syndrome.
    Yuki N
    J Infect Dis; 1997 Dec; 176 Suppl 2():S150-3. PubMed ID: 9396700
    [TBL] [Abstract][Full Text] [Related]  

  • 15. T cell response in acute motor axonal neuropathy.
    Cencioni MT; Notturno F; Caporale CM; Creati B; Prencipe V; Battistini L; Uncini A
    Int J Immunopathol Pharmacol; 2009; 22(4):1043-50. PubMed ID: 20074468
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of Campylobacter jejuni serotype with antiganglioside antibody in Guillain-Barré syndrome and Fisher's syndrome.
    Yuki N; Takahashi M; Tagawa Y; Kashiwase K; Tadokoro K; Saito K
    Ann Neurol; 1997 Jul; 42(1):28-33. PubMed ID: 9225682
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Experimental axonopathy induced by immunization with Campylobacter jejuni lipopolysaccharide from a patient with Guillain-Barré syndrome.
    Caporale CM; Capasso M; Luciani M; Prencipe V; Creati B; Gandolfi P; De Angelis MV; Di Muzio A; Caporale V; Uncini A
    J Neuroimmunol; 2006 May; 174(1-2):12-20. PubMed ID: 16516981
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Monoclonal antibodies raised against Guillain-Barré syndrome-associated Campylobacter jejuni lipopolysaccharides react with neuronal gangliosides and paralyze muscle-nerve preparations.
    Goodyear CS; O'Hanlon GM; Plomp JJ; Wagner ER; Morrison I; Veitch J; Cochrane L; Bullens RW; Molenaar PC; Conner J; Willison HJ
    J Clin Invest; 1999 Sep; 104(6):697-708. PubMed ID: 10491405
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Campylobacter gene polymorphism as a determinant of clinical features of Guillain-Barré syndrome.
    Koga M; Takahashi M; Masuda M; Hirata K; Yuki N
    Neurology; 2005 Nov; 65(9):1376-81. PubMed ID: 16162859
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lipopolysaccharides in the development of the Guillain-Barré syndrome and Miller Fisher syndrome forms of acute inflammatory peripheral neuropathies.
    Prendergast MM; Moran AP
    J Endotoxin Res; 2000; 6(5):341-59. PubMed ID: 11521055
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.